Your Article Summary
GSK Grabs Derma Firm for $2.9 Billion
PharmExec, 04/27/09
GlaxoSmithKline announced on Monday that it would purchase the total share capital of Stiefel Laboratories for $2.9 billion cash. Stiefel is a big name in the dermatology world, touting 30 subsidiaries, six manufacturing plants, an internal R and D system, and a network of approximately 3,500 global associates.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
IMS Predicts 4% to 6% Global Pharma Market Growth Next Year
U.S. Pharmacist, 12/02/09
CryoLife Provides Initial 2010 Financial Guidance
Cryolife, 12/02/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy
BayNews International, 12/02/09
Article Search
Sponsor


See Latest Articles


